SOUTH SAN FRANCISCO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, and the Aligos management team, will present at the 2023 Piper Sandler Healthcare Conference being held in New York on Thursday, November 30, 2023 at 12:30 p.m. ET.
Piper Sandler Healthcare Conference Information:
| Date | Thursday, November 30, 2023 | ||
| Time: | 12:30 p.m. ET | ||
| Presenter: | Lawrence Blatt, Ph.D., MBA, CEO of Aligos | ||
| Webcast: | Link here |
A replay of the session will be available following the conference for 90-days through the Aligos investor section of the website https://investor.aligos.com/.
The Aligos management team will also participate in investor 1×1 meetings during the conference. Please contact your Piper Sandler representative to schedule one-on-one meetings with Aligos during the conference.
About Aligos
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral diseases. Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver and viral diseases to discover and develop potentially best in class therapeutics for nonalcoholic steatohepatitis (NASH) and viruses with high unmet medical need such as coronaviruses and chronic hepatitis B (CHB).
Media Contact
Veronica Eames
LifeSci Communications
veames@lifescicomms.com
Investor Contact
Corey Davis, Ph.D.
LifeSci Advisors
+1 212 915 2577
cdavis@lifesciadvisors.com
